Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Obsessive-Compulsive Disorder Drugs Market: By Product: SSRI, TCA, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, EMR’s Key Indicators for Demand, EMR’s Key Indicators for Price; Competitive Landscape; Industry Events and Developments

Global Obsessive-Compulsive Disorder Drugs Market Outlook

The global obsessive-compulsive disorder drugs market is projected to grow at a CAGR of almost 4.8% over the forecast period of 2022-2027.

 

The global obsessive-compulsive disorder drugs market is being driven by the rising investment in R&D and health care sector, the rapid development in the OCD treatment procedures, and the growing demand for off-level drugs and therapies.

 

Global Obsessive Compulsive Disorder Drugs Market Report

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Obsessive-compulsive disorder (OCD) is a medical condition characterised by unreasonable thoughts and obsessions or fears, which leads to compulsive behaviour in an individual. Antidepressants are often the first medications prescribed to treat OCD.

The global obsessive-compulsive disorder drugs market can be divided on the basis of segments like products and regions.

 

Global Obsessive-Compulsive Disorder Drugs Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

  • Product:
    • SSRI
    • TCA
    • Others

The EMR report looks into the regional obsessive-compulsive disorder drugs markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Obsessive-Compulsive Disorder Drugs Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The development of new drugs to treat the obsessive-compulsive disorder is one of the major factors driving the growth of the industry globally. With rising consumer awareness, the demand for drugs with enhanced bioavailability, safety, and dosage parameters has increased, leading manufacturers to focus on the R&D of new OCD drugs. Thus, the launch of these products is expected to aid the growth of the obsessive-compulsive disorder drugs industry over the forecast period. Further, the growing acceptance of off-label drugs in combination with the approved therapies is providing a boost to the industry.

The SSRI segment, among other product types, dominated the industry in 2020, owing to the presence of several SSRIs including fluoxetine, fluvoxamine, paroxetine, and others, coupled with their fewer side effects in comparison to other drug types. Further, North America accounted for the largest share in the industry in 2020 due to the rising prevalence of obsessive-compulsive disorder and increased government initiatives in the region to combat this condition. The region is expected to dominate the obsessive-compulsive disorder drugs market in the forecast period as well.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global obsessive-compulsive disorder drugs industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Eli Lilly and Company
  • GlaxoSmithKline plc 
  • H. Lundbeck A/S 
  • Pfizer Inc. 
  • Lupin Limited
  • Others

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Region
Breakup by Product SSRI, TCA, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Eli Lilly and Company, GlaxoSmithKline plc, Lupin Limited, Pfizer Inc., H. Lundbeck A/S, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface  
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Obsessive-Compulsive Disorder Drugs Market Analysis 

    8.1    Key Industry Highlights
    8.2    Global Obsessive-Compulsive Disorder Drugs Historical Market (2017-2021) 
    8.3    Global Obsessive-Compulsive Disorder Drugs Market Forecast (2022-2027)
    8.4    Global Obsessive-Compulsive Disorder Drugs Market by Product
        8.4.1    SSRI
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    TCA
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Others
    8.5    Global Obsessive-Compulsive Disorder Drugs Market by Region
        8.5.1    Market Share
            8.5.1.1    North America
            8.5.1.2    Europe
            8.5.1.3    Asia Pacific
            8.5.1.4    Latin America
            8.5.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis 
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Eli Lilly and Company
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    GlaxoSmithKline plc
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Lupin
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Pfizer Inc.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    H. Lundbeck A/S
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments


List of Key Figures and Tables

1.    Global Obsessive-Compulsive Disorder Drugs Market: Key Industry Highlights, 2017 and 2027
2.    Global Obsessive-Compulsive Disorder Drugs Historical Market: Breakup by Product (USD Million), 2017-2021
3.    Global Obsessive-Compulsive Disorder Drugs Market Forecast: Breakup by Product (USD Million), 2022-2027
4.    Global Obsessive-Compulsive Disorder Drugs Historical Market: Breakup by Region (USD Million), 2017-2021
5.    Global Obsessive-Compulsive Disorder Drugs Market Forecast: Breakup by Region (USD Million), 2022-2027
6.    North America Obsessive-Compulsive Disorder Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
7.    North America Obsessive-Compulsive Disorder Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
8.    Europe Obsessive-Compulsive Disorder Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
9.    Europe Obsessive-Compulsive Disorder Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
10.    Asia Pacific Obsessive-Compulsive Disorder Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
11.    Asia Pacific Obsessive-Compulsive Disorder Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Latin America Obsessive-Compulsive Disorder Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Latin America Obsessive-Compulsive Disorder Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Middle East and Africa Obsessive-Compulsive Disorder Drugs Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Middle East and Africa Obsessive-Compulsive Disorder Drugs Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Global Obsessive-Compulsive Disorder Drugs Market Structure

Key Questions Answered in the Report

The global obsessive-compulsive disorder drugs market is further likely to grow at a CAGR of 4.8% in the forecast period of 2022 and 2027.

The major drivers of the industry include the rising investment in the R&D and health care industry, development of new drugs to treat the obsessive-compulsive disorder, rising consumer awareness, and increased government initiatives.

The rapid development in the OCD treatment procedures, and the growing demand for off-level drugs and therapies are the key factors driving industry growth globally.

The major regions in the industry are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The major products in the industry are SSRI and TCA, among others.

The key players in the industry are Eli Lilly and Company, GlaxoSmithKline Plc, Lupin, H. Lundbeck A/S, and Pfizer Inc., among others.

Analyst Review

The global market for obsessive-compulsive disorder drugs is driven by growing investment in the R&D and health care industry in recent years.  Aided by the development of new drugs to treat the obsessive-compulsive disorder and rising consumer awareness, the market is projected to grow at a CAGR of 4.8% in the forecast period of 2022-2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product, the industry can be segmented into SSRI and TCA, among others. The major regional markets for obsessive-compulsive disorder drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Eli Lilly and Company, GlaxoSmithKline Plc, Lupin, H. Lundbeck A/S, and Pfizer Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER